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This issue presents several reviews, 
primers and essays on applied 
neuroscience covering everything 
from computer vision and pain to the 
law. Neuroscience is often driven by 
pure curiosity: how does the brain 
work? How does such complexity 
evolve? Is there an underlying code 
that is the equivalent of DNA for the 
mind? There are certainly mysteries 
galore. But unlike other curiosity-driven 
areas like cosmology or astrophysics, 
neuroscience is rich in applications. 
Like genetics and biology, it has 
the potential, some of which is now 
being realized, to provide not just 
answers, but cures, for pathologies 
and traumas, and applications of new 
brain–computer interfaces. Neural 
prosthetics of all kinds, for hearing, 
sight, lost or paralyzed limbs, and the 
brain–machine interfaces that make 
them run are becoming more and more 
commonplace. Certainly, cochlear 
implants have become the poster child 
of applied neuroscience, soon to reach 
500,000 people who now have some 
form of hearing. Vision implants are 
progressing, although much more 
slowly. Deep brain stimulation to help 
Parkinson’s disease and depression, 
among other conditions, is now a 
growing success story. Recovery of 
motor control for paralyzed limbs has 
begun as the field of brain-controlled 
prosthetics takes off. And a better 
understanding of the neural basis of 
choice provides a more solid grounding 
for legal issues of ethics and morality. 
These are good days for real 
applications of neuroscience that 
will make deep and meaningful 
contributions to society. And yet, 
neuroscience is still a small player in 
science funding. Although individual 
projects in other disciplines receive 
massive funding, like the Large Hadron 
Collider at $9bn, the ITER fusion 
reactor, $7bn, the Cassini-Huygens 
satellite $3.3bn, and development for 
just one drug, Lipitor, $4bn, last year 
all of US neuroscience received only 
$5.5bn, about 15% of the NIH budget, 
divided among 16,000 projects. The US 
Guest Editorial BRAIN Initiative at $4.5bn over 12 years and the now controversial European 
Human Brain Project at $1.6bn over 
10 years are encouraging, though 
dwarfed by the $100bn it took to land 
on the moon. For the moment, there is 
nowhere near this level of funding to, 
how should we say it, land science on 
the cortex. 
Beyond this central core of 
burgeoning applications, like deep 
brain stimulation, cochlear implants, 
and brain-controlled prosthetics, 
lies a great number of growing and 
even eclectic new directions. Many of 
these involve applying neuroscience to 
artificial intelligence. Long ago it was 
the fashion to make computers solve 
problems as humans might, attempting 
to transfer expertise in vision, language, 
and chess, among other areas, into 
working code. “Computers will defeat 
the top grand master in chess in 
10 years,” said Herb Simon in 1957. 
In fact, it took 40 years, and not by 
using any methods that resembled 
human expertise. Artificial intelligence 
approaches to language and vision 
also abandoned any pretense to mimic 
biological processes and migrated to 
brute-force data techniques. But the 
pendulum has now begun to swing 
back and biology-inspired approaches 
are being reconsidered, whether with 
deep learning or voice interpretation 
in severe noise or biomimetic and 
‘attentive’ robots. Even further afield, 
applications of neurosciences stretch 
in many unexpected directions. These 
innovations can be as unbounded and 
unpredictable as the basic research 
that inspires them. Some of these 
eclectic directions are seen in this 
issue, with the coverage of applications 
of neuroscience to law, economics, and 
social sciences. 
This review of applications should 
be a truly encouraging sign that 
neuroscience is meeting its goals 
in providing new ways to overcome 
pathologies, improve quality of life, and 
extend neuroscience into new areas 
of applications. New neuroscience 
projects that are vast in diversity and 
massive in scale are bringing promising 
applications, together with the science 
behind them, to the next level. 
In their review, Richard Andersen and 
coauthors describe how to derive the 
intent of the subject by tapping into 
cortical areas upstream of the motor 
cortex. This new approach will add 
to the range of interfaces available 
for current work on the control of paralyzed limbs and prosthetic artificial 
limbs, using implanted stimulators that 
augment residual signals in damaged 
spinal cord. These new techniques for 
direct brain control show great promise, 
but are just beginning, having reached 
nowhere near the wide application of 
cochlear implants. 
Simon Little and Peter Brown cover 
three truly encouraging advances made 
in previously intractable neurological 
disorders, driven by primary 
neuroscience. Pharmacogenetics 
genetically provides replacement for 
lost dopamine; adaptive deep brain 
stimulation can now be controlled by 
neural signals; and finally, optogenetics 
provides the opportunity to repair 
large-scale, network-level dysfunctions. 
Deep brain stimulation follows cochlear 
implants as a remarkable achievement 
of neuroscience, with about 100,000 
implants worldwide for treatment of 
Parkinson’s as well as headache, 
Tourette’s, epilepsy, and now 
psychiatric disorders like depression, 
and anxiety.
Frank Sengpiel reviews the evidence 
for neural plasticity and argues that 
indeed the brain can regenerate. 
Recent animal studies suggest that 
visual cortex plasticity in particular 
can be restored or enhanced later in 
life by removing the molecular brakes 
that normally limit plasticity to an early 
critical period. 
Dario Floreano and coauthors 
give an overview of the work at 
the intersection of robotics and 
neuroscience and highlight the most 
promising approaches and areas 
where interactions between the two 
fields have generated significant new 
developments for both fields. They 
argue that the physical behavior and 
embodiment inherent in robotics 
generate valuable insight into the 
function of nervous systems, and that, 
in return, neurally inspired algorithms 
and devices are able to give robots 
life-like capabilities.
Cox and Dean take a look at 
neuroscience-inspired computer vision 
starting from early models of McCulloch 
and Pitts and Rosenblatt, through the 
connectionist era and its subsequent 
abandonment, to the deep-learning 
models of the present day. Following 
the early connectionist boom of the 
1980s, neural models were supplanted 
by engineered solutions to particular 
computer vision problems that avoided 
any biological strategies. This long 
“A.I. Winter” was relieved by the arrival 
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Thought control of robotic limbs: By imagining the movement of her own arms, a paralysed 
woman controls a robotic arm to serve herself some coffee, the first time in 15 years that she 
has been able to do so. An array of 96 electrodes implanted in her motor cortex records signals 
for the imagined limb movement and these are then converted into commands to the robotic 
arm. (Photo: braingate2.org)of deep-learning techniques with 
multiple layers mimicking the many-
layered structure of the visual cortex. 
The success of these new techniques 
can be seen from the enormous 
investment of industry giants such as 
Google, Facebook, and Baidu. Over 
a short period of time, neural network 
models went from an obscure relic of the 
past to a dominant force in nearly every 
field of machine learning and perception. 
Cox and Dean review several aspects 
of biological neural computing that may 
be incorporated in the new models. 
Feedback is becoming important but, 
in contrast, modeling neurons at the 
spiking level has yet to be shown to be 
useful. They suggest that models should 
move to analyzing dynamic images and 
incorporating interactions with working 
memory, reward, and other senses. 
According to Cox and Dean, we are 
seeing the start of a new era when the 
fields of neuroscience, computer vision, 
and machine learning have more to say 
to one another than ever before.
In their primer, Essi Viding and 
coauthors describe how neuroimaging 
approaches are providing insights into 
psychopathy, a personality disorder 
that harms both the affected individual 
and society in general. They point 
out that the challenge for the field 
is to translate the new research into 
new intervention techniques and that research in some areas such as 
empathy induction and punishment 
has shown limited success for treating 
psychopathy.
In a complementary Primer, Singer 
and Klimecki describe recent findings 
on empathy and compassion, the 
traits that seem to be defective 
in psychopaths, from social and 
affective neuroscience. Neuroimaging 
has suggested, for example, that 
empathizing with another person’s 
feelings relies on the activation of 
neural networks that also support 
the first-person experience of these 
feelings. Further research focuses on 
socio-affective training techniques to 
affect functional brain plasticity, brain 
structure, and a wide range of health 
and behavior-related variables.
In a mini review, Zhang and Seymour 
present an overview of pain treatment. 
Why does pain have to hurt so much? 
New technologies for chronic pain 
management also offer prospects for 
measuring and diagnosing pain. They 
also describe how new optogenetic 
techniques have the potential to 
transform pain control. 
Colin Camerer’s Primer explains 
how the neural basis of economics is 
progressing rapidly, helped along by 
the fact that mathematical expressions 
of neural computation can be 
compared to the mathematics used to describe economic-utility maximization. 
He also describes the efforts to 
combine data from many studies with 
socioeconomic outcomes and genome-
wide association data to greatly 
improve the statistical power available 
to identify associations. 
Machery and Carlyon explain the 
essentials of cochlear implants, the 
first example of a neural prosthesis 
that can substitute for a sensory 
organ. These have become a standard 
clinical procedure for congenitally 
deaf children. Many cochlear implant 
listeners can use the telephone and 
follow auditory-only conversations in 
quiet environments. They describe 
how sounds are degraded as a result 
of both device and sensory limitations, 
and discuss current research trends 
aiming to improve speech perception, 
particularly in challenging listening 
conditions. 
Finally, in one of three wide-ranging 
essays, Vincent Walsh tackles a 
new approach to neuroscience 
through sport. He points out that elite 
athletes provide an unrecognized 
opportunity to explore neural activity 
at its top level in natural settings. 
Consider the precision and pace of 
response when Rafael Nadal faced 
Novak Djokovic in the Wimbledon 
final in June: their performance 
required extraordinarily rapid visual 
processing, strategic and motor 
planning, as well as action. Walsh 
emphasizes that current laboratory 
approaches cannot or have not yet 
investigated the levels of processing 
speed, bandwidth, and intermodule 
coordination seen in sport. The 
neuroscience of sport is not just the 
study of remarkable individuals with 
differently constructed, freakishly 
fast nervous systems. Instead, elite 
performance identifies the processing 
architectures necessary for real, 
complex behavior and this applies 
to all of our nervous systems even if 
with less elegant outcomes and lower 
prize winnings. 
In his essay, John Tsotsos considers 
the various degrees of overlap 
between biological and computer 
vision. He points out that biology is 
capable of fast, general vision, and 
skilled performance, both requiring 
computational complexity that would 
overwhelm any current artificial 
technologies. Tsotsos reviews the 
strategies from neuroscience that are 
being transferred to artificial systems 
in an attempt to get them up to our 
Special Issue
R851
Melancholic mind: The artist Edvard Munch (1863–1944) suffered from severe anxiety and has 
in his work depicted various states of emotional distress, including depression: this painting is 
called Evening. Melancholy I. (1896). (Image: Wikipedia.)speed in complex tasks. For example, 
one important constraint to reduce 
complexity is attention, the selection of 
a subset of the input data or a subset 
of potential outputs that focus on the 
most relevant options. Strategies are 
now being developed to operationalize 
‘attention’ and other biologically based 
approaches, and transport them to 
intelligent devices. 
And in a third essay, Buckholtz and 
Faigman bring in the law. After all, 
once the new brain–machine interfaces 
are in place, who is to blame when 
your prosthetic arm kills someone? 
These instances where we might look 
to the technology to find responsibility 
for our actions shade into cases 
where our better understanding of the 
neuroscience of behavior suggests 
neural sources for antisocial acts. 
We can blame murder on Ambien 
or Twinkies, on YYX chromosomes 
or on just being male. Where does 
responsibility fall, morally and legally, 
once we have more comprehensive 
explanations of violent behavior from 
neuroscience. How reliable is the use 
of neuroscience as evidence in court. 
Buckholtz and Faigman consider 
the difficulty of evaluating scientists’ 
testimony as well as the use of fMRI or 
other biomarkers of lying, and the use 
of predictive constraints on individuals 
with neural correlates of antisocial 
behavior. Neuroscience, perhaps more 
than any other science, will become 
increasingly involved in deciding 
legal cases and policy. Buckholtz 
and Faigman offer some guidance to 
the issues that will be raised as this 
progresses. 
In reading through these reviews, 
primers, and essays, it is clear that 
neuroscience is now a major player 
in medicine and the development of 
new learning and legal methods. At 
one time, a ‘moon shot’ meant that 
your project was ambitious but had 
almost no chance of succeeding. But, 
of course, we did land on the moon, 
and neuroscience has now reached a 
level of maturity and progress where a 
‘moon shot’ for neuroscience should 
mean just that, a massive moon-
landing level of investment to bring the 
fruits of neuroscience, many on display 
in this special issue, to society.
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Hollywood actor Robin Williams 
triggered a global discussion about 
mental health, bringing out all the 
manifold questions, uncertainties, 
misconceptions and prejudices 
that surround problems like major 
depressive disorder (depression) 
and bipolar disorder, which is what 
Williams reportedly suffered from and 
which involves alternating phases of 
depression and euphoria. 
By its very nature, views on a 
suicide in the state of depression 
depend on people’s philosophy and 
outlook on life. Reactions range from 
the view that depression is a deadly 
disease like cancer and suicide is 
just its fatal symptom, through to 
the description of suicide as an 
act of free will designed to escape 
an unbearable situation. Charities 
like the Samaritans and Mind 
have warned that the latter view, if 
propagated in the media, may trigger 
further suicides, as may the reporting 
of excessive detail of the ways and 
means employed in the act. However, 
with the global media competing 
over this exceptional story, this 
advice was frequently neglected in 
the reporting. 
In the wake of Williams’ death, 
attention turned to the broader issues 
of depression, which is widespread 
but still widely misunderstood. Major 
depression, according to a definition 
from US psychiatrist Allen Frances, 
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Depression has become one of the biggest health problems globally, but in 
certain places more than in others, suggesting cultural as well as biological 
causes. Neuroscientists are only beginning to understand underlying processes 
and to develop effective treatments for those cases where conventional 
psychotherapy and drugs fail. Michael Gross reports.
Silver linings for patients with depression?
